Norethindrone And Ethinyl Estradiol Kit
Product Images NDC 79929-007

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norethindrone And Ethinyl Estradiol (NDC 79929-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-11.jpg (Blister 11)

Norethindrone and Ethinyl Estradiol Tablets USP 1 mg/0.035 mg 28-day dosage calendar card by Naari Pte Limited. The label includes circles arranged by day and week for tracking daily tablet intake, with instructions to peel and place the correct day label. Storage instructions note temperatures 256C (776F) with excursions permitted to 156C to 306C (596F to 866F).*

FDA Label Image

Blister-22 (Blister 22)

Norethindrone and Ethinyl Estradiol Tablets USP 1 mg/0.035 mg 28-Day kit blister packaging label. The label shows a four-week daily pill tracker with circles for each day of the week and week numbers 1 to 4. Illustrations guide the user to peel and place correct day labels. The label includes storage instructions and manufacturer information for Naari Pte Ltd.*

FDA Label Image

Blister-33 (Blister 33)

Norethindrone and Ethinyl Estradiol Tablets, USP 1 mg/0.035 mg 28-Day oral contraceptive kit pack label. The label includes a calendar with circles arranged in a 4-week grid for daily pill tracking, with days of the week noted. Instructions indicate where to place the correct day label and start week label. Labeler is Naari Pte Limited.*

FDA Label Image

Figure-2 (Figure2)

A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' displaying effect estimates (Odds Ratios/Relative Risks) from eight different studies. Each study's estimate is shown as a dot and horizontal confidence interval line plotted against a centered vertical line of 1.0 on the x-axis, representing no effect. The chart includes studies from 2002 to 2017 with risk estimates ranging roughly between 0.9 and 1.3.*

FDA Label Image

Figure 1 (Nor Ethi Fig1)

A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across various age groups (15-24, 25-34, 35-44, and 45+). The chart compares four groups: ever users (non-smokers), controls (non-smokers), ever users (smokers), and controls (smokers), illustrating higher mortality in smokers and older age groups.*

FDA Label Image

Chemical Structure (Nor Ethi Str)

Chemical structure diagram showing two active ingredients: Norethindrone and Ethinyl estradiol. Each structure is labeled with the respective compound name, depicting molecular arrangements typical for these hormonal substances.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.